Your Article Summary
See Latest ArticlesRisk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations
Climacteric, 07/01/09
Schneider C et al. - The study provides evidence that estradiol/dydrogesterone use of several months to a few years is not associated with a higher risk of cardiovascular events than use of other HRT.
Related Articles
Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations
Climacteric, 11/16/09
Relevance Score: 80%
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/30/09
Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
International Journal of Women's Health, 11/30/09
Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome
Diabetes Research and Clinical Practice, 11/25/09